Biomarker Turnaround Times and Impact on Treatment Decisions in Patients with Advanced Non-Small Cell Lung Carcinoma at a Large Canadian Community Hospital with an Affiliated Regional Cancer Centre

Conclusions: This study emphasizes the need for the expansion of regional resources to meet the clinical needs of advanced NSCLC patients treated at a regional cancer centre which uses an off-site molecular laboratory.PMID:38534948 | PMC:PMC10969576 | DOI:10.3390/curroncol31030115

Source: Current Oncology - March 27, 2024 Category: Cancer & Oncology Authors: Katelyn E Fleming Ava Hupel Hamid Mithoowani Tea Lulic-Kuryllo Mario Valdes Source Type: research